Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hepatitis B vaccine (AusperBio)
- Development stage
- Unknown
- Lead developer
- AusperBio
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The hepatitis B vaccine used by Ausper Biopharma is an immunotherapeutic agent being evaluated as part of a combination therapy for the treatment of chronic hepatitis B (CHB). In the Phase II clinical trial NCT07069569 (AB-10-8007), the vaccine is administered in conjunction with AHB-137, an antisense oligonucleotide (ASO) that suppresses hepatitis B surface antigen (HBsAg) expression and viral replication. The therapeutic rationale is that reducing the viral antigen load with AHB-137 may alleviate immune exhaustion, allowing the hepatitis B vaccine to effectively stimulate a host immune response (immune reactivation) to achieve a functional cure, characterized by sustained HBsAg loss and undetectable HBV DNA.
- Other names
- HBV vaccineHepatitis B therapeutic vaccine
02
Targets
HBsAg (Hepatitis B surface antigen)
Beyond the preview
Go deeper on hepatitis B vaccine (AusperBio).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hepatitis B vaccine (AusperBio).